Meme stocks are a contentious topic.  Many traditional investors criticizing the lack of solid business fundamentals for supporting previous rapid increases in stock prices.  Others suggest that companies with a speculative nature should see rapid movements. It’s all part of the investing game, and if short-sellers get caught flat-footed, so be it. The past two
0 Comments
Investing would be a lot easier if you didn’t have to worry about underperforming stocks to get rid of. Wouldn’t it be great if stocks did what you thought they would do when you bought them? But that’s part of the game you play when you invest in the stock market. We can use tools, metrics
0 Comments
There is a healthy debate right now about whether growth stocks are on the upswing. On the one hand, growth names have rallied sharply to start 2023. On the other, the factors that sunk growth shares in 2022 remain present. The tech industry is facing layoffs, revenue growth is down, and higher interest rates continue
0 Comments
After bouncing back strongly at the start of 2023, AMC Entertainment (NYSE:AMC) stock has traded sideways in more recent months. Currently at around $5 per share, AMC stock may look tempting, for risk-hungry investors bullish that the popular “meme stock” will soon resume making big moves. Unfortunately, while shares in the movie theater chain may
0 Comments
When it comes to investing for the long-haul, blue-chip stocks may first come to mind. However, alongside these venerable, steady names, adding a few of the best stocks to buy for long-term growth may be another profitable decision to make. The emphasis here, of course, is on “long-term,” rather than merely “growth.” There are plenty
0 Comments
Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indicates that experts project the global economic cost of cancers from 2020 to 2050 will be $25.2 trillion (in constant 2017 dollar terms). Therefore, finding a cure would
0 Comments
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can’t just buy companies based on any one single metric. In addition, sometimes a very cheap PE can actually signal significant fundamental problems. Instead,
0 Comments
Without question, tech has been the best-performing group so far in 2023. Understandably, that’s got investors looking at the best tech stocks to buy.  At the same time though, that does create a tough situation. On the one hand, investors want to stick with what’s working. The mentality of “The trend is your friend” has
0 Comments
Welcome to another week of Hypergrowth Investing, folks! With earnings season underway, we’re laser-focused on companies’ first-quarter results and what that means for stocks going forward. As we’ve mentioned previously, in the first three months of this year, both the labor market and consumer spending were quite resilient. And those two factors should support strong
0 Comments